Flamingo Therapeutics

Foundation date

04/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.

Upcoming events

Latest news

  • reMYND announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease

    Friday November 1st 2024

  • Can we protect nerve cells from dying?

    Friday November 1st 2024

  • Resistance in Candida auris, how to tackle a deadly fungus

    Wednesday October 30th 2024